Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.
Hepatitis B reactivation due to chemotherapy is a cause of serious morbidity and mortality in some of the patients with cancer. In this study, we retrospectively assessed the prevalence of hepatitis B reactivation among the patients undergoing cytotoxic chemotherapy. We investigated efficacy of lamivudine prophylaxis against hepatitis B reactivation as well.
Eren
Orhan Onder
OO
Department of Internal Medicine, Division of Medical Oncology, Selcuk University Meram Medical Faculty, Konya, Turkey. droneren@hotmail.com
Artac
Mehmet
M
Boruban
Melih Cem
MC
Yavas
Ozlem
O
Arslan
Ugur
U
Basaranoglu
Metin
M
D019380:Anti-HIV Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000378:metabolism*; D006515:Hepatitis B virus / Q000187:drug effects / Q000254:growth & development*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000821:virology*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014775:Virus Activation / Q000187:drug effects*
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D006514:Hepatitis B Surface Antigens; D019259:Lamivudine